Acta neuropathologica 2018-11
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".   
ABSTRACT

Related Questions

Do molecular factors (1p/19q, IDH status) influence your choice of dose/volumes?

When would you offer hypofractionated radiotherapy?